RxDoctor Payments Data

Tammy Sparks, APRN

Family · Cameron, MONPI 1699215921

Payments from drug & device makers

$1,027in general payments, 2019–2025

Across 52 payments — averaging $19.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$211
  • Lundbeck LLC$138
  • Lilly USA, LLC$132
  • AbbVie$127
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$87
  • Johnson & Johnson$65
  • plus $266 from 12 others

What the payments were for

  • Food & beverage$92090%
  • Education$10710%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,027 in reported general payments places this provider in the 65th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$1,451
Medicare patients
25
Services billed
48

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide25$21,279
XareltoRivaroxaban18$14,022
FarxigaDapagliflozin Propanediol17$13,928
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl57$7,930
Duloxetine Hcl49$1,360
Atorvastatin Calcium163$1,303
Omeprazole95$1,016
Levothyroxine Sodium93$901
Potassium Chloride55$896
Albuterol Sulfate HfaAlbuterol Sulfate37$767
Gabapentin48$735
Carbidopa-LevodopaCarbidopa/Levodopa18$713
Lisinopril125$704
Pregabalin27$573
Celecoxib33$548

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$16$21,27925 claims
Johnson & JohnsonXarelto$65$14,02218 claims
AstraZenecaFarxiga$16$13,92817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,812 family providers in Missouri.

Other family in Cameron

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →